Can acute mastoiditis be managed on an outpatient basis in an uncomplicated patient?

Management of Acute Mastoiditis: Outpatient vs Inpatient

Uncomplicated acute mastoiditis can be safely managed on an outpatient basis with parenteral antibiotics, provided the patient has no neurologic deficits, sepsis, subperiosteal abscess, or bony erosion, and close follow-up is ensured. 1, 2

Defining Uncomplicated Mastoiditis

The key to determining outpatient eligibility lies in accurate classification:

• Truly uncomplicated mastoiditis excludes patients with intracranial complications, subperiosteal abscess (SPA), AND any evidence of bony erosion including coalescence 3
• The traditional definition that only excluded intracranial complications and SPA is insufficient—bony erosion must also be absent 3
• Patients without neurologic deficits or sepsis are candidates for conservative management 1

Outpatient Treatment Protocol

Initial management approach:

• Daily intravenous ceftriaxone is the standard outpatient regimen with a 93% cure rate 2
• Wide myringotomy should be performed at initiation of treatment 4
• Daily visits by otolaryngology and infectious disease specialists are essential for monitoring 4
• Average duration of IV antibiotic therapy is approximately 5 days for outpatient cases 2

When to Hospitalize

Immediate hospitalization is required for:

• Presence of fever (patients with complications are more likely to be febrile) 2
• Subperiosteal abscess 1, 3
• Any bony erosion or coalescence on imaging 3
• Neurologic deficits or sepsis 1
• Intracranial complications 1, 3
• Failure to improve after 48 hours of outpatient therapy 1, 2

Evidence Supporting Outpatient Management

Success rates demonstrate safety and efficacy:

• Medical therapy alone (antibiotics) has a 24.6% success rate when used as sole initial treatment 5
• Conservative therapy with antibiotics plus myringotomy achieves 95.9-96.3% cure rates 6
• Outpatient parenteral antibiotic therapy shows 96.8% clinical cure rate when combined with myringotomy 4
• Only 2 of 27 outpatients (7%) failed therapy and required admission 2

Clinical Algorithm

Step 1: Confirm diagnosis and assess for complications

• Obtain CT temporal bones with IV contrast if diagnosis uncertain or complications suspected 1
• Look for bony erosion, coalescence, SPA, or intracranial pathology 3

Step 2: Risk stratify

• Low risk (outpatient candidates): No fever, no bony erosion, no SPA, no neurologic deficits, reliable follow-up available 3, 2
• High risk (hospitalize): Fever present, any bony changes, SPA, neurologic symptoms, or uncertain follow-up 2

Step 3: Initiate treatment

• Outpatient: Daily IM ceftriaxone + myringotomy with daily specialist visits 2, 4
• Inpatient: IV antibiotics (ampicillin-sulbactam or ceftriaxone) ± myringotomy ± drainage procedures 7

Step 4: Reassess at 48 hours

• If no improvement or clinical deterioration, obtain CT scan and consider mastoidectomy 1
• Mastoidectomy rates vary from 29-93% depending on practice patterns, not necessarily disease severity 1

Important Caveats

Common pitfalls to avoid:

• Do not rely on normal inflammatory markers to exclude mastoiditis—white blood cell count may be normal 7
• Prior antibiotic treatment for AOM does not eliminate risk of mastoiditis (33-81% of mastoiditis patients had received prior antibiotics) 1
• Imaging is warranted in cases not resolving promptly, as clinical signs cannot reliably distinguish those with intracranial complications 1
• Mastoidectomy is not routinely required for uncomplicated cases—only 10% of Swedish cases needed antibiotics alone, 68% needed antibiotics plus myringotomy 1

Benefits of outpatient management include:

• Efficient use of hospital beds 2
• Cost savings 2
• Patient and family convenience 2
• Shorter total duration of IV antibiotics (4.9 days outpatient vs 18.9 days inpatient) 2